FIELD: chemistry.
SUBSTANCE: application of compound (S)-2-(3-aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-1,3,4-thiadiazole-3(2H)-carboxamide in maximally tolerable dose for intensification of process of apoptosis of patient's cells, having pathogenic cells in state of delay in mitosis, induced by said compound, after its introduction.
EFFECT: invention ensures high efficiency of apoptosis.
17 cl, 19 dwg, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION OF CHEKPOINT-KINASE 1 INHIBITORS AND WEE 1 KINASE INHIBITORS | 2011 |
|
RU2627841C2 |
| INHIBITORS OF CELL CYCLE CHECKPOINT KINASE 1 FOR AMPLIFICATION OF DNA-DAMAGING AGENTS | 2010 |
|
RU2567044C2 |
| COMPOUND FOR TREATING CANCER | 2014 |
|
RU2708247C2 |
| COMBINATION CONTAINING N-METHOXY-3-METHYLPYRAZINE-2-YL)-2-(4-[1,3,4-OXADIAZOL-2-YL]PHENYL)PYRIDINE-3-SULFONAMIDE AND ANTIMITOTIC SUBSTANCE FOR MALIGNANT GROWTH | 2005 |
|
RU2428188C2 |
| COMBINATION THERAPY WITH ANTITUMOR ALKALOID | 2018 |
|
RU2757373C2 |
| FUCOSIDASE INHIBITORS | 2016 |
|
RU2765202C2 |
| ON01910NA ENHANCING ACTIVITY OF CHEMOTHERAPEUTIC AGENT IN DRUG-RESISTANT TUMOURS | 2008 |
|
RU2476239C2 |
| COMBINATION THERAPY WITH ANTICANCER ALKALOID | 2018 |
|
RU2767664C2 |
| SYNERGIC METHODS AND COMPOSITIONS FOR CANCER TREATMENT | 2001 |
|
RU2264217C2 |
| COMPOSITION FOR PREVENTING CHEMORESISTANCE TO ANTIMITOTIC AGENTS | 2022 |
|
RU2807691C1 |
